Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Cell Mol Neurobiol ; 39(3): 401-414, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30739252

ABSTRACT

Maternal diabetes constitutes an unfavorable intrauterine environment for offspring development. Although it is known that diabetes can cause brain alterations and increased risk for neurologic disorders, the relationship between neuroimmune activation, brain changes, and neurodevelopment deficits in the offspring remains unclear. In order to elucidate the short- and long-term biological basis of the developmental outcomes caused by the severe uncontrolled maternal hyperglycemia, we studied apoptosis, neurogenesis, and neuroinflammation pathways in the hippocampus of neonates and young rats born to diabetic dams. Diabetes was induced on gestational day 5 by an injection of streptozotocin. Evaluations of milestones, body growth, and inhibitory avoidance were performed to monitor the offspring development and behavior. Hippocampal modifications were studied through cellular survival by BrdU in the dentate gyrus, expression of apoptosis-regulatory proteins (procaspase 3, caspase 3, and Bcl-2), BDNF, and neuroinflammatory modulation by interleukins, MHC-I, MHC-II, Iba-1, and GFAP proteins. Severe maternal diabetes caused microsomia and neurodevelopmental delay in pups and decrease of Bcl-2, procaspase 3, and caspase 3 in the hippocampus. Moreover, in a later stage of development, it was found an increase of TNF-α and a decrease of procaspase 3, caspase 3, MHC-I, IL-1ß, and BDNF in the hippocampus, as well as impairment in cellular survival in the dentate gyrus. This study showed significant short- and long-term commitments on the development, apoptosis, cell survival, and neuroinflammation in the offspring hippocampus induced by severe uncontrolled maternal hyperglycemia. The data reinforce the need for treatment of maternal hyperglycemic states during pregnancy and breast-feeding.


Subject(s)
Apoptosis , Hippocampus/growth & development , Hippocampus/pathology , Hyperglycemia/complications , Inflammation/pathology , Prenatal Exposure Delayed Effects/pathology , Adrenal Glands/pathology , Animals , Animals, Newborn , Avoidance Learning , Body Weight , Brain-Derived Neurotrophic Factor/metabolism , Cell Survival , Cytokines/metabolism , Female , Glucose Tolerance Test , Liver/pathology , Organ Size , Pregnancy , Rats, Wistar , Streptozocin , Thymus Gland/pathology
2.
J Exerc Rehabil ; 14(3): 489-496, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30018938

ABSTRACT

The purpose of the current study was to investigate whether locomotor stimulation training could have beneficial effects on spinal cord plasticity consequent to sensorimotor restriction (SR). Male Wistar rats were exposed to SR from postnatal day 2 (P2) to P28. Control and experimental rats underwent locomotor stimulation training in a treadmill from P31 to P52. The intensity of the synaptophysin and caspase-3 immunoreaction was determined on ventral horn of spinal cord. The synaptophysin immunoreactivity was lower in the ventral horn of sensorimotor restricted rats compared to controls animals and was accompanied by an increased caspase-3 immunoreactivity. Those alterations were reversed at the end of the training period. Our results suggest that immobility affects the normal developmental process that spinal cord undergoes in early postnatal life influencing both pro-apoptotic and synapse markers. Also, we demonstrated that this phenomenon was reversed by 3 weeks of treadmill training.

3.
Brain Res ; 1592: 101-12, 2014 Dec 10.
Article in English | MEDLINE | ID: mdl-25446006

ABSTRACT

This study evaluated the effects of resveratrol on locomotor behaviors, neuronal and glial densities, and tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta of rats with streptozotocin-induced diabetes. Animals were divided into four groups: non-diabetic rats treated with saline (SAL), non-diabetic rats treated with resveratrol (RSV), diabetic rats treated with saline (DM) and diabetic rats treated with resveratrol (DM+RSV). The animals received oral gavage with resveratrol (20 mg/kg) for 35 days. The open field test and the bar test were performed to evaluate bradykinesia and akinesia, respectively. The Nissl-stained neuronal and glial densities and the dopaminergic neuronal density were estimated using planar morphometry. Tyrosine hydroxylase immunoreactivity was evaluated using regional and cellular optical densitometry. In relation to the locomotor behaviors, it was observed that the DM group developed akinesia, which was attenuated by resveratrol in the DM+RSV group, while the DM and DM+RSV groups showed bradykinesia. Our main morpho-physiological results demonstrated: a decrease in the cellular tyrosine hydroxylase immunoreactivity in the DM group, which was attenuated by resveratrol in the DM+RSV group; a higher neuronal density in the RSV group, when compared to the DM and DM+RSV groups; an increase in the glial density in the DM group, which was also reversed by resveratrol in the DM+RSV group. Resveratrol treatment prevents akinesia development and restores neuronal tyrosine hydroxylase immunoreactivity and glial density in the substantia nigra pars compacta of diabetic rats, suggesting that this polyphenol could be a potential therapeutic option against diabetes-induced nigrostriatal dysfunctions.


Subject(s)
Diabetes Mellitus, Experimental/physiopathology , Dyskinesias/prevention & control , Neuroprotective Agents/pharmacology , Pars Compacta/drug effects , Stilbenes/pharmacology , Tyrosine 3-Monooxygenase/metabolism , Animals , Diabetes Mellitus, Experimental/pathology , Dyskinesias/pathology , Dyskinesias/physiopathology , Male , Motor Activity/drug effects , Neuroglia/drug effects , Neuroglia/pathology , Neuroglia/physiology , Neurons/drug effects , Neurons/pathology , Neurons/physiology , Pars Compacta/pathology , Pars Compacta/physiopathology , Random Allocation , Rats, Wistar , Resveratrol
4.
Behav Brain Res ; 263: 149-57, 2014 Apr 15.
Article in English | MEDLINE | ID: mdl-24486258

ABSTRACT

Cerebral palsy (CP) results from nonprogressive lesions in the immature brain generating changes on the neuromuscular system. Environmental enrichment (EE) is a combination of stimuli that provides greater motivation and interest in novel movement exploration through the provision of various devices associated to enhanced social stimulation that would mimic the physiotherapy approach. The aim of this study was to verify whether EE is able to prevent the establishment of motor impairment in a CP rat model. The animals were divided in two groups: control animals (healthy) and animals submitted to a CP model. After this, the pups were exposed to two environments: enriched or standard, totaling four groups: Control group (without CP in a standard environment), CP group (CP model in a standard environment), EE group (without CP in an enriched environment) and CP-EE (CP model in an enriched environment). The experimental model was induced in pregnant Wistar rats by the association of maternal exposure to bacterial endotoxin, perinatal anoxia and sensorimotor restriction of the pups. The assessment of motor skills was held using the following tests: open field, rotarod, horizontal ladder, narrow suspended bar and stride length. The histological analysis evaluated the mean cross-sectional area (CSA) of the soleus muscle fibers, the mean CSA of motoneuronal somata and expression of synaptophysin in the ventral horn of the spinal cord. EE was able to prevent the motor deficits, however, it did not reverse the muscle atrophy observed in CP animals. Furthermore, there was an average increase in the mean area of motoneurons and an increase in the expression of synaptophysin in the ventral horn of the spinal cord of the CP-EE group in relation to CP animals reared in a standard environment. Hereupon, the stimulus increment provided by EE can prevent the onset of motor deficits and histological changes in a CP rat model.


Subject(s)
Cerebral Palsy/physiopathology , Cerebral Palsy/therapy , Environment , Motor Skills , Spinal Cord/pathology , Animals , Anterior Horn Cells/metabolism , Anterior Horn Cells/pathology , Body Weight , Cerebral Palsy/complications , Cerebral Palsy/pathology , Disease Models, Animal , Housing, Animal , Motor Neurons/metabolism , Motor Neurons/pathology , Muscle, Skeletal/pathology , Muscular Atrophy/etiology , Muscular Atrophy/pathology , Muscular Atrophy/therapy , Organ Size , Rats , Rats, Wistar , Secondary Prevention , Spinal Cord/metabolism , Synaptophysin/metabolism , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...